Automated High Throughput Drug Screening Integrated System_Galatek

OFFICIALMAIL@GALATEK.AI
Automated High Throughput Drug Screening Integrated System
Automated High Throughput Drug Screening Integrated System
As AI and machine learning reshape drug screening toward greater precision and efficiency, the industry is overcoming long-standing obstacles such as limited compound diversity, complex data interpretation, and demanding biological validation processes. Galatek stands at the forefront of this shift, offering comprehensive automation that seamlessly integrates into the entire screening pipeline. By transforming and automating the full workflow, we empower researchers to accelerate the development of new therapies with enhanced reliability and speed.

Product Introduction

High-Throughput Drug Screening Platform

High Throughput Nanoliter Drug Screening Platform

Multimodal Drug Screening Platform

 High-Throughput Drug Screening Platform
 High-Throughput Drug Screening Platform

The high-throughput drug screening functional island automates the complete small-molecule testing workflow. It manages the entire process from compound serial dilution and cell culture handling to assay preparation, incubation, and final readout, seamlessly integrating each step. The system is specifically engineered for efficient compound screening and enzymology studies in 96/384-well formats.

High Throughput Nanoliter Drug Screening Platform
High Throughput Nanoliter Drug Screening Platform

The High Throughput Nanoliter Drug Screening Platform seamlessly orchestrates the entire screening workflow, from initial sample preparation and assay setup to final culture, detection, and data analysis. It delivers precision dispensing at nanoliter volumes and accommodates a range of standard formats, from 96-well to 1536-well plates and compound storage cryotubes. By integrating with the Galatek Data Intelligence Platform, the system leverages advanced analytics and dynamic threshold management to rapidly identify target compounds. This comprehensive solution is tailored for medium to high throughput drug discovery programs in both corporate and academic research environments.

Multimodal Drug Screening Platform
Multimodal Drug Screening Platform
Multimodal Drug Screening Platform

The Multimodal Drug Screening Platform automates complete cell-based assay workflows, encompassing steps from cell seeding and feeding to compound dosing and subsequent processing. Its integrated software allows for intuitive protocol design and intelligent task scheduling. The platform is an unified solution, compatible with major detection modalities including live-cell imaging, high-content analysis, microplate reading, and ELISA.

Solution Feature

Fast and Efficient
Fast and Efficient
Daily screening throughput of 10,000 to 50,000 compounds, significantly improving efficiency compared to manual screening
Standardized Control
Standardized Control
Strictly regulate and standardize experimental workflows through a standardized data platform and automated experimental platform
Information Traceability and Sharing
Information Traceability and Sharing
Full-process labeling and barcode recognition; each compound is assigned a unique code, enabling full traceability of information
No Dead-angle Liquid Aspiration and Disposal
No Dead-angle Liquid Aspiration and Disposal
Proprietary developed tilting module ensures liquid aspiration and disposal with no residue and no dead agles
Significant Cost Reduction
Significant Cost Reduction
Using nanoliter dispensing devices, single dispensing volume reduced from 1 μL to 25 nL, lowering cost to 1/40 of manual dispensing and saving precious samples
Rapid Screening of Target Compounds
Rapid Screening of Target Compounds
Intelligent data platform efficiently analyzes drug results, predicting compound activity and toxicity, significantly accelerating candidate drug discovery

Product Parameter

Basic ParametersDescription
Dimensions2,450 mm(W) * 2,450 mm(D) * 2,600 mm(H)
Compatible Plate Types96/384-well plates
Daily Screening ThroughputApprox. 10,000 to 20,000 compounds (384-well plates)
Environment ControlPositive/Negative pressure laminar flow hood, UV

Application Scenarios

Study on Components of Traditional Chinese Medicin
Study on Components of Traditional Chinese Medicin
High-throughput Screening of Small Molecule Compou
High-throughput Screening of Small Molecule Compou
Organoid-based Drug Sensitivity and Screening Assa
Organoid-based Drug Sensitivity and Screening Assa
Drug Sensitivity Screen in Zebrafish Model
Drug Sensitivity Screen in Zebrafish Model
Nucleic Acid Drug Research
Nucleic Acid Drug Research
Antibody Drug Research
Antibody Drug Research
Peptide Drug Development
Peptide Drug Development
Stem Cell-based Drug Research
Stem Cell-based Drug Research

Solution Feature

Fast and Efficient
Fast and Efficient
Daily screening throughput of 10,000 to 50,000 compounds, significantly improving efficiency compared to manual screening
Standardized Control
Standardized Control
Strictly regulate and standardize experimental workflows through a standardized data platform and automated experimental platform
Information Traceability and Sharing
Information Traceability and Sharing
Full-process labeling and barcode recognition; each compound is assigned a unique code, enabling full traceability of information
No Dead-angle Liquid Aspiration and Disposal
No Dead-angle Liquid Aspiration and Disposal
Proprietary developed tilting module ensures liquid aspiration and disposal with no residue and no dead agles
Significant Cost Reduction
Significant Cost Reduction
Using nanoliter dispensing devices, single dispensing volume reduced from 1 μL to 25 nL, lowering cost to 1/40 of manual dispensing and saving precious samples
Rapid Screening of Target Compounds
Rapid Screening of Target Compounds
Intelligent data platform efficiently analyzes drug results, predicting compound activity and toxicity, significantly accelerating candidate drug discovery

Product Parameter

Basic ParametersDescription
Dimensions4,200 mm(W) * 2,450 mm(D) * 2,600 mm(H)
Compatible Plate Types96/384/1536-well plates, cryotubes
Daily Screening ThroughputApprox. 30,000 to 50,000 compounds (384-well plates)
Environment ControlPositive/Negative pressure laminar flow hood, UV

Application Scenarios

Study on Components of Traditional Chinese Medicin
Study on Components of Traditional Chinese Medicin
High-throughput Screening of Small Molecule Compou
High-throughput Screening of Small Molecule Compou
Organoid-based Drug Sensitivity and Screening Assa
Organoid-based Drug Sensitivity and Screening Assa
Drug Sensitivity Screen in Zebrafish Model
Drug Sensitivity Screen in Zebrafish Model
Nucleic Acid Drug Research
Nucleic Acid Drug Research
Antibody Drug Research
Antibody Drug Research
Peptide Drug Development
Peptide Drug Development
Stem Cell-based Drug Research
Stem Cell-based Drug Research

Solution Feature

Fast and Efficient
Fast and Efficient
Daily screening throughput of 10,000 to 50,000 compounds, significantly improving efficiency compared to manual screening
Standardized Control
Standardized Control
Strictly regulate and standardize experimental workflows through a standardized data platform and automated experimental platform
Information Traceability and Sharing
Information Traceability and Sharing
Full-process labeling and barcode recognition; each compound is assigned a unique code, enabling full traceability of information
No Dead-angle Liquid Aspiration and Disposal
No Dead-angle Liquid Aspiration and Disposal
Proprietary developed tilting module ensures liquid aspiration and disposal with no residue and no dead agles
Significant Cost Reduction
Significant Cost Reduction
Using nanoliter dispensing devices, single dispensing volume reduced from 1 μL to 25 nL, lowering cost to 1/40 of manual dispensing and saving precious samples
Rapid Screening of Target Compounds
Rapid Screening of Target Compounds
Intelligent data platform efficiently analyzes drug results, predicting compound activity and toxicity, significantly accelerating candidate drug discovery

Product Parameter

Basic ParametersDescription
Dimensions5,000 mm(W) * 2,450 mm(D) * 2,600 mm(H)
Compatible Plate Types96/384/1536-well plates, cryotubes
Daily Screening ThroughputApprox. 30,000 to 50,000 compounds (384-well plates)
Environment ControlPositive/Negative pressure laminar flow hood, UV

Application Scenarios

Study on Components of Traditional Chinese Medicin
Study on Components of Traditional Chinese Medicin
High-throughput Screening of Small Molecule Compou
High-throughput Screening of Small Molecule Compou
Organoid-based Drug Sensitivity and Screening Assa
Organoid-based Drug Sensitivity and Screening Assa
Drug Sensitivity Screen in Zebrafish Model
Drug Sensitivity Screen in Zebrafish Model
Nucleic Acid Drug Research
Nucleic Acid Drug Research
Antibody Drug Research
Antibody Drug Research
Peptide Drug Development
Peptide Drug Development
Stem Cell-based Drug Research
Stem Cell-based Drug Research

Contact us

Have read and accepted the Privacy Policy and Terms of Service
Download document
Have read and accepted the Privacy Policy and Terms of Service